SCHEMBL30796781

SCHEMBL30796781

CC(C)(C)OC(=O)N1CCN(c2ccnc(-c3cc(Cl)nnc3N)c2)C(=O)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMARCA2 P51531 2/20 0.42
▸ SMARCA4 P51532 2/20 0.42
▸ PBRM1 Q86U86 2/20 0.42
▸ POLB P06746 1/20 0.38
▸ ENPP2 Q13822 2/20 0.38
▸ NR1H2 P55055 1/20 0.37
▸ ESR2 Q92731 1/20 0.36
▸ P2RX7 Q99572 1/20 0.35
▸ MAP4K4 O95819 1/20 0.35
▸ GPR119 Q8TDV5 1/20 0.34
▸ CHRNA7 P36544 1/20 0.34
▸ LRRK2 Q5S007 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ GRM1 Q13255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ SUV39H2 Q9H5I1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27461346 1.00 SMARCA2 (0.42) SMARCA2SMARCA4PBRM1POLBENPP2
SCHEMBL30796853 0.87 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1POLBMAP4K4
SCHEMBL27461169 0.87 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1POLBMAP4K4
SCHEMBL27461347 0.83 SMARCA2 (0.47) SMARCA2SMARCA4PBRM1ENPP2NR1H2
SCHEMBL30796952 0.83 SMARCA2 (0.47) SMARCA2SMARCA4PBRM1ENPP2NR1H2
SCHEMBL18502950 0.78 WNT3A (0.44) POLBENPP2NR1H2ESR2GPR119
SCHEMBL27461344 0.77 NR1H2 (0.42) POLBENPP2NR1H2ESR2GPR119
SCHEMBL30796230 0.76 GRM1 (0.47) GRM1CNR1
SCHEMBL30796546 0.76 NR1H2 (0.41) POLBENPP2NR1H2ESR2MAP4K4
SCHEMBL30796736 0.75 SMARCA2 (0.41) SMARCA2SMARCA4PBRM1POLBENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4539849-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 Therapeutics, Inc. (US) 2025-04-23 — — EP disclosed
WO-2023244764-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 THERAPEUTICS, INC. (US) 2023-12-21 — — WO disclosed
Send feedback